Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation

Liver International

Volumn 35, Issue 9, 2015, Pages 2174-2186

  Ajamieh, Hussam ^a   Farrell, Geoffrey C ^a   Mccuskey, Robert S ^b   Yu, Jun ^c   Chu, Eagle ^c   Wong, Heng Jian ^a   Lam, Wesley ^a   Teoh, Narci C ^a  

^a CANBERRA HOSPITAL   (Australia)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atorvastatin; Cytokines; Microvascular protection; Non alcoholic fatty liver disease; Toll like receptor 4

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOXANE B2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CHEMOKINE; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOS3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY LIVER; LIVER INJURY; LIVER PROTECTION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; UPREGULATION; ANIMAL; BLOOD; LIVER; MALE; METABOLISM; MOUSE MUTANT; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANIMALS; ATORVASTATIN CALCIUM; CHEMOKINES; CYTOKINES; HMGB1 PROTEIN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; MALE; MICE; MICE, OBESE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; NON-ALCOHOLIC FATTY LIVER DISEASE; REPERFUSION INJURY; THROMBOXANE B2; TOLL-LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84938993369     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12827     Document Type: Article

References (15)

1. Zhai Y, Petrowsky H, Hong JC, Busittil R, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation - from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79-89.
2. Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 2008; 291: 684-92.
3. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011; 26(Suppl 1): 173-9.
4. Elias-Miro M, Jimenez-Castro MB, Rodes J, Peralta C. Current knowledge on xidative stress in hepatic ischemia/reperfusion. Free Radic Res 2013; 47: 555-68.
5. Teoh NC, Ito Y, Field J, et al. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 2007; 133: 632-46.
6. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 2013; 59: 1094-106.
7. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57.
8. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
9. Nace GW, Huang H, Klune JR, et al. Cellular specific role of toll-like receptor 4 in hepatic ischemia reperfusion injury in mice. Hepatology 2013; 58: 374-87.
10. Meimei H, Dejin M, Erzhen C, et al. Inhibiting the toll-like receptor 4/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice. Crit Care Med 2014; 42: 123-31.
11. Rivera CA, Adegboyega P, van Rooijen N, et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007; 47: 571-9.
12. Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and Toll-like receptor 4 expression attenuates non-alcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2011; 300: G433-41.
13. Teoh NC, Williams J, Hartley J, et al. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14, 643 protects murine fatty liver against ischemia-reperfusion injury. Hepatology 2010; 51: 996-1006.
14. Atar S, Ye Y, Lin Y, et al. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol 2006; 290: H1960-8.
15. Dibazar F, Hajipour B, Hosseinian MM, Hemmati MR, Ghandiha A. Simvastatin decreases hepatic ischaemia/reperfusion-induced liver and lung injury in rats. Folia Morphol 2008; 67: 231-5.